Nexeon Medsystems (NXNN) & SONOVA Hldg AG/ADR (SONVY) Head to Head Review
Nexeon Medsystems (OTCMKTS: SONVY) and SONOVA Hldg AG/ADR (OTCMKTS:SONVY) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, earnings, risk, valuation and institutional ownership.
Earnings & Valuation
This table compares Nexeon Medsystems and SONOVA Hldg AG/ADR’s gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Nexeon Medsystems||$3.30 million||3.88||-$2.17 million||($3.64)||-1.79|
|SONOVA Hldg AG/ADR||$2.43 billion||5.45||$354.51 million||N/A||N/A|
Insider and Institutional Ownership
0.2% of SONOVA Hldg AG/ADR shares are held by institutional investors. 61.2% of Nexeon Medsystems shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.
This table compares Nexeon Medsystems and SONOVA Hldg AG/ADR’s net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|SONOVA Hldg AG/ADR||N/A||N/A||N/A|
This is a summary of recent recommendations for Nexeon Medsystems and SONOVA Hldg AG/ADR, as reported by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|SONOVA Hldg AG/ADR||0||0||0||0||N/A|
SONOVA Hldg AG/ADR pays an annual dividend of $0.30 per share and has a dividend yield of 0.7%. Nexeon Medsystems does not pay a dividend.
SONOVA Hldg AG/ADR beats Nexeon Medsystems on 8 of the 9 factors compared between the two stocks.
About Nexeon Medsystems
Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.
About SONOVA Hldg AG/ADR
Sonova Holding AG designs, develops, manufactures, and distributes hearing systems for adults and children with hearing impairment. It offers hearing instruments, cochlear implants, wireless communication products, and rechargeable hearing aids, as well as professional audiological services. The company provides hearing instruments under the Phonak, Unitron, and Hansaton brand names; cochlear implants under the Advanced Bionics brand name; and professional audiological services under the Connect Hearing brand name. Sonova Holding offers its products through a sales and distribution network, which comprise approximately 50 Sonova-owned wholesale companies and 100 independent distributors; and AudioNova retail network of approximately 3,300 locations in 12 markets. It operates in the Americas, Europe, the Middle East, Africa, and the Asia/Pacific. The company was formerly known as Phonak Holding AG and changed its name to Sonova Holding AG in August 2007. Sonova Holding AG was founded in 1947 and is headquartered in Stäfa, Switzerland.
Receive News & Ratings for Nexeon Medsystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nexeon Medsystems and related companies with MarketBeat.com's FREE daily email newsletter.